PeptideStack
5.2kquestions
20kanswers
220users

Is 97.1% a realistic purity ceiling for tirzepatide given its chain length?

Asked 28 Jan 2025Modified 18 months agoViewed 3.2k times
5

Conditions: 97.1% · tirzepatide.

Please show the division. I want to check my own against yours.

I would like the general form as well as the specific number, so I can apply it again.

Where is my error, and what is the correct working?

purity
purity

Purity as chromatographic area per cent - the fraction of detected material that is your target peak. It says nothing about how much material is…

833 questionshplc
hplc

Reverse-phase high-performance liquid chromatography, the workhorse purity method. Column chemistry, mobile-phase choice, gradient slope,…

503 questionspeptide-mapping
peptide-mapping

Enzymatic digestion followed by LC-MS/MS to confirm sequence rather than just mass. The method that catches a scrambled sequence or a D-amino-acid…

103 questionstirzepatide
tirzepatide

A dual GIP and GLP-1 receptor agonist. Questions here cover the SURPASS and SURMOUNT programmes, the practical differences from a pure GLP-1…

370 questions
shareeditfollowflag
RS
askedrota_site36k2728 Jan 2025
3Is the comparison against a supplier certificate or against a second independent result? – u100_marks 9 months ago
2Voting to keep this open — it is more specific than it first looks. – ruaidhri_o_shea 8 months ago
add a comment

No answers yet

This question has not been answered. It has been viewed 3.2k times, which suggests the question is of interest and the answer is not obvious. If you can answer it with a source or a worked calculation, it will be read. See how to ask and answer.
Sponsored

Sigma-Aldrich - Certified Reference Materials

Analytical standards and reagents with traceable certificates. Every quantitative result you read inherits the accuracy of the standard behind it.

Shop standards

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.